BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31159521)

  • 1. [Clinical features and genetic characteristics of 33 patients with simple virilizing form of 21-hydroxylase deficiency].
    Zeng LT; Han B; Liu BL; Chen X; Zhu H; Chen Y; Chen M; Liu JH; Liu Y; Qiao J
    Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):428-434. PubMed ID: 31159521
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY
    J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of CYP21A2 gene mutations and the differences in the levels of hormones in patients with 21-hydroxylase deficiency].
    Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):586-592. PubMed ID: 32164112
    [No Abstract]   [Full Text] [Related]  

  • 5. Rare combination of simple virilizing form of 21-hydroxylase deficiency, Graves' disease and 47, XXX in a woman: A case report.
    Liang D; Han M; Xu L; Ren Y; Zhang Y; Yin J; Yang J; Liu Y
    Medicine (Baltimore); 2022 Oct; 101(43):e31443. PubMed ID: 36316845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis and novel variation identification in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Xia Y; Shi P; Gao S; Liu N; Zhang H; Kong X
    J Steroid Biochem Mol Biol; 2022 Sep; 222():106156. PubMed ID: 35882282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern China.
    Hou L; Liang L; Lin S; Ou H; Liu Z; Huang S; Zhang L; Meng Z
    Steroids; 2019 Nov; 151():108474. PubMed ID: 31446012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
    Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
    Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for congenital adrenal hyperplasia: transitory elevation of 17-hydroxyprogesterone.
    Huidobro Fernández B; Echeverria Fernández M; Dulin Iñiguez E; Ezquieta Zubicaray B; Roldán Martín MB; Rodríguez Arnao MD; Rodríguez Sánchez A
    J Pediatr Endocrinol Metab; 2011; 24(3-4):155-62. PubMed ID: 21648283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype in the diagnosis of 21-hydroxylase deficiency: who should undergo CYP21A2 analysis?
    Cavarzere P; Vincenzi M; Teofoli F; Gaudino R; Lauriola S; Maines E; Camilot M; Antoniazzi F
    J Endocrinol Invest; 2013 Dec; 36(11):1083-9. PubMed ID: 24081139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China.
    Su L; Yin X; Cheng J; Cai Y; Wu D; Feng Z; Liu L
    Clin Chim Acta; 2018 Nov; 486():142-150. PubMed ID: 30048636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygosis for CYP21A2 mutation considered as 21-hydroxylase deficiency in neonatal screening.
    Soardi FC; Lemos-Marini SH; Coeli FB; Maturana VG; Silva MD; Bernardi RD; Justo GZ; de-Mello MP
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1388-92. PubMed ID: 19169499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
    Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
    Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital adrenal hyperplasia in adolescents: diagnosis and management.
    Lin-Su K; Nimkarn S; New MI
    Ann N Y Acad Sci; 2008; 1135():95-8. PubMed ID: 18574213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
    Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of phenotypes and genotypes in 66 patients with 21-hydroxylase deficiency identified by neonatal screening].
    Wang RF; Gu XF; Ye J; Han LS; Qiu WJ; Zhang HW; Yu YG; Gong ZW
    Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):679-85. PubMed ID: 27596083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
    Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
    Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.